Streetbeat News

Revenues

PR

Six analysts have recently updated their ratings on Permian Resources (NYSE:PR), with a mix of bullish, somewhat bullish, and indifferent stances. The average 12-month price target is now $16.00, down from $17.00, with a high estimate of $18.00 and a low of $14.00. Analysts from RBC Capital, B of A Securities, UBS, Stifel, Wells Fargo, and Susquehanna have provided various ratings and price target adjustments. Permian Resources has shown a revenue growth rate of 37.97% as of September 30, 2023, but has below-average net margin, ROE, and ROA, with a conservative debt-to-equity ratio of 0.63.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 4:00 pm

DNA

Ginkgo Bioworks Holdings (NYSE:DNA) has received mixed reviews from financial analysts, with 2 bearish and 2 indifferent ratings in the past quarter. The average 12-month price target is $1.8, up from the previous $1.25, with a high estimate of $2.50 and a low of $1.10. Goldman Sachs analyst Matthew Sykes lowered the price target to $1.10 from $1.25, maintaining a 'Sell' rating, while Raymond James analyst Rahul Sarugaser announced a 'Market Perform' rating with a $2.50 target. Ginkgo Bioworks faces challenges with a -16.52% revenue decline, a net margin of -546.44%, and an ROE of -21.98%, but maintains a low debt-to-equity ratio of 0.32.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 4:00 pm

SEMR

SEMrush Hldgs (NYSE:SEMR) received mixed analyst ratings over the past three months, with 1 bullish and 3 indifferent ratings. The average 12-month price target is $12.75, up from $11.67, with a high of $15.00 and a low of $10.00. Analysts from Goldman Sachs, Piper Sandler, Needham, and Morgan Stanley have updated their ratings and price targets. SEMrush's financials show strong market capitalization, revenue growth, net margin, ROE, ROA, and a low debt-to-equity ratio, indicating solid financial health and market confidence.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 4:00 pm

UAL

United Airlines CEO stated in a conference call that the company's revenues will adapt to the new cost reality. The CEO also expressed confidence that United will be able to maintain and grow its earnings per share (EPS) and profit margins.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 3:45 pm

UAL

United Airlines CEO stated in a conference call that the company has managed to offset higher-than-expected costs with higher-than-expected revenue, despite industry-wide cost pressures leading to increased CASM-ex. The CEO also mentioned that supply chain challenges are expected to persist for the foreseeable future.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 3:44 pm

GATX

GATX Corporation (NYSE:GATX) reported Q4 revenues of $368.70 million, surpassing estimates of $365.40 million, and adjusted EPS of $1.74, beating the consensus of $1.58. The company saw significant growth in non-dedicated engine revenue and provided a positive 2024 earnings guidance of $7.30–$7.70 per share, above the expected $7.00. Shares rose by 6.80% to $126.71 following the news.

Portfolio Pulse from Nabaparna Bhattacharya

January 23, 2024 | 3:44 pm

GOLD

Barrick Gold Corporation's Lumwana copper mine Super Pit expansion in Zambia is on track for first production in 2028. The project, costing nearly $2 billion, aims to transform Lumwana into a major copper mine with an annual output of 240,000 tonnes over 30+ years. The mine has been restructured since 2019, contributing $3 billion to Zambia's economy and focusing on local procurement and community development through initiatives like the Business Accelerator Program and REDD+ for conservation.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 3:36 pm

PRPO

Precipio, Inc. (NASDAQ:PRPO) reported a significant reduction in its Cash Burn From Operations (CBFO) for Q4-2023, dropping below $100K, a more than 90% decrease from the previous quarter. The company's end-of-quarter cash balance decreased slightly from $1.5M to $1.4M. Despite this progress, management cautions that Q1-2024 may not show similar results due to seasonal declines in the pathology business and insurance payment delays. However, the Q4 results demonstrate Precipio's potential to reach cash flow breakeven and the company's confidence in its business model and market share growth.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 3:06 pm

IGC

IGC Pharma, Inc. (NASDAQ:IGC) shares rose after announcing preclinical trial data for TGR-63, a drug candidate for Alzheimer's, showing significant plaque reduction. The company aims to move TGR-63 into human trials, inspired by the FDA's approval of similar drugs. The news resulted in heavy trading volume, with over 2.77 million shares traded compared to a 100-day average of under 204,000 shares.

Portfolio Pulse from Erica Kollmann

January 23, 2024 | 3:05 pm

QTWO

Q2 Holdings (NYSE:QTWO) has received diverse ratings from 8 analysts, with an average 12-month price target of $40.12, reflecting a 19.16% increase from the previous target. Analysts from firms like Goldman Sachs and Morgan Stanley have raised their price targets, indicating a positive outlook for QTWO. The company provides cloud-based virtual banking solutions and has shown a revenue growth rate of 7.06% as of September 30, 2023. However, it faces challenges with a net margin of -14.95% and an ROA of -1.97%, though it has a favorable debt-to-equity ratio of 1.24.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 3:01 pm